Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
2004
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: dissertation (non GLP, non guideline)

Data source

Reference
Reference Type:
other: dissertation
Title:
Allergien durch Hexamethylentetramin - Eine Querschnittuntersuchung in einer Produktionsanlage
Author:
Topcu, M.
Year:
2004
Bibliographic source:
Inaugural-Dissertation zur Erlangung des Doktorgrades der Medizin einer Hohen Medizinischen Fakultät der Ruhr-Universität Bochum

Materials and methods

Type of sensitisation studied:
skin
Study type:
survey
Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Public avaialble literature. No guideline indicated. For details on method see materials and methods section.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Methenamine
EC Number:
202-905-8
EC Name:
Methenamine
Cas Number:
100-97-0
Molecular formula:
C6H12N4
IUPAC Name:
1,3,5,7-tetraazatricyclo[3.3.1.1³,⁷]decane
Test material form:
solid: crystalline

Method

Type of population:
occupational
Ethical approval:
not specified
Subjects:
17 industrial workers of the methenamine production site of INEOS Paraform GmbH & Co. KG (formerly Degussa) in Mainz, Germany (8 persons with strong exposure, 5 shift leaders, and 4 Managers and technicans).
Control group: 16 workers from the same company (10 had rarely contact with the test substance).
Clinical history:
A questionnaire about clinical history (sensitisation data) was answered by all workers.
Controls:
Control group: 16 workers from the same company (10 had rarely contact with the test substance).
Route of administration:
other: dermal and inhalation
Details on study design:
The following parameters were investigated:
- patch tests
- concentration of total IgE
- lung function
- exposition monitoring

Results and discussion

Results of examinations:
- A skin sensitisation potential of methenamine was observed in two persons exposed to high doses of the test substance and in one former worker of the plant.

- patch tests: no positive results in treatment and control group.

- concentration of total IgE: not significantly difference between exposure and control group.

- lung function: not significantly difference between exposure and control group.

- exposure monitoring: geometric mean between 1.5 and 0.3 mg/m3 total dust (depending of workplace)

Applicant's summary and conclusion

Conclusions:
Methenamine was shown to cause skin sensitisation effects to humans. No correlation between exposure to methenamine and occurrace of allergic asthma can be seen.
Executive summary:

Based on these results no correlation between exposure to methenamine and occurrace of allergic asthma can be seen. The number of subjects was too small for a complete evaluation.

A skin sensitisation potential of methenamine was observed in two persons exposed to high doses of the test substance and in one former worker of the plant.